发明名称 Adrenomedullin and adrenomedullin binding protein for ischemia/reperfusion treatment
摘要 Methods of treating a mammal at risk for ischemia-reperfusion injury are provided. The methods comprise administrating an adrenomedullin binding protein-1 (AMBP-1) to the mammal in sufficient amount to reduce the injury. Also provided are methods of treating a mammal at risk for ischemia-reperfusion injury to the bowel. The methods comprise administering adrenomedullin to the mammal in sufficient amount to reduce the injury.
申请公布号 US9101593(B2) 申请公布日期 2015.08.11
申请号 US201414193284 申请日期 2014.02.28
申请人 The Feinstein Institute for Medical Research 发明人 Wang Ping
分类号 A61K38/22;A61K38/17 主分类号 A61K38/22
代理机构 Amster, Rothestein & Ebenstein LLP 代理人 Amster, Rothestein & Ebenstein LLP
主权项 1. A method of treating a mammal at risk for ischemia-reperfusion injury to a kidney, the method comprising administering an amount of adrenomedullin binding protein-1 (AMBP-1) and adrenomedullin to the mammal effective to reduce ischemia-reperfusion injury to a mammalian kidney.
地址 Manhasset NY US